Neuroprotective Potential of Novel Multi-Targeted Isoalloxazine Derivatives in Rodent Models of Alzheimer's Disease Through Activation of Canonical Wnt/β-Catenin Signalling Pathway

Neurotoxicity Research
Jatin MachhiMange Ram Yadav

Abstract

Previous reports suggest that Alzheimer's disease is protected by cholinesterase inhibitors. We synthesized some isoalloxazine derivatives and evaluated them using in vitro cholinesterase inhibition assay. Two of the compounds (7m and 7q) were figured out as potent cholinesterase inhibitors. They further showed anti-Aβ aggregatory activity in the in vitro assay. The current study deals with the evaluation of neuroprotective potentials of the potent compounds (7m and 7q) using different in vitro and in vivo experiments. The compounds were first assessed for their tendency to cross blood-brain barrier using in vitro permeation assay. They were evaluated using scopolamine-induced amnesic mice model. Additionally, ROS scavenging and anti-apoptotic properties of 7m and 7q were established against Aβ1-42-induced toxicity in rat hippocampal neuronal cells. 7m and 7q were also evaluated using Aβ1-42-induced Alzheimer's rat model. Lastly, their involvement in Wnt/β-catenin pathway was also demonstrated. The results indicated good CNS penetration for 7m and 7q. The neuroprotective effects of 7m and 7q were evidenced by improved cognitive ability in both scopolamine and Aβ1-42-induced Alzheimer's-like condition in rodents. The in vivo res...Continue Reading

References

Jun 8, 2000·Journal of Medicinal Chemistry·P CrivoriB Testa
Oct 26, 2000·Nature·M O Hengartner
Aug 23, 2001·Brain Research. Brain Research Reviews·R D'Hooge, P P De Deyn
Sep 15, 2001·Journal of Neuropathology and Experimental Neurology·K A Roth
Oct 13, 2001·Brain Research. Molecular Brain Research·S BrechtT Herdegen
Jul 5, 2002·The Journal of Biological Chemistry·Carol M TroyWilma J Friedman
Oct 25, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·José L GarridoNibaldo C Inestrosa
Feb 4, 2003·Nature Reviews. Neuroscience·Sultan DarveshChangiz Geula
Apr 2, 2003·European Journal of Medicinal Chemistry·Li DiGuy T Carter
Jul 1, 1961·Biochemical Pharmacology·G L ELLMANR M FEATHER-STONE
Jul 3, 2004·The Journal of Clinical Investigation·Dennis W Dickson
Dec 2, 2004·Brain Research. Brain Research Reviews·Rodrigo A FuentealbaNibaldo C Inestrosa
Feb 4, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Mingzhong YaoChristian J Pike
Jan 27, 2006·The Cochrane Database of Systematic Reviews·J Birks
Aug 26, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Jera JerucDusan Ferluga
Oct 5, 2006·Brain : a Journal of Neurology·Hans-Wolfgang KlafkiJens Wiltfang
Dec 16, 2006·Current Alzheimer Research·Mathew Blurton-Jones, Frank M Laferla
Apr 5, 2007·Nature Protocols·Stefanie Kaech, Gary Banker
Jun 1, 2007·Nature Reviews. Drug Discovery·Irena Melnikova
Nov 2, 1979·Science·J C HathawayD A Sangrey
Jan 22, 2008·The FEBS Journal·Nibaldo C InestrosaAlejandra Alvarez
Jul 8, 2008·Neurochemistry International·Magdolna Pákáski, János Kálmán
Dec 23, 2008·Ageing Research Reviews·Rick A C M BoonenDanica Zivkovic
May 22, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ping He, Yong Shen
Aug 25, 2009·Nature Neuroscience·Zhengliang GaoJenny Hsieh
Aug 25, 2009·Nature Neuroscience·Tomoko KuwabaraFred H Gage
Jan 12, 2010·Journal of Alzheimer's Disease : JAD·M Paul Murphy, Harry LeVine
Feb 24, 2010·The Biochemical Journal·Kirsty E A MuirheadFrank J Gunn-Moore
Mar 2, 2010·Nature Reviews. Drug Discovery·Adriano Aguzzi, Tracy O'Connor
Dec 24, 2010·Cell Communication and Signaling : CCS·Ganta Vijay ChaitanyaPhanithi Prakash Babu
Feb 4, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Chun-Yan WangZhan-You Wang
Sep 29, 2011·Frontiers in Molecular Neuroscience·Francisco J Carvajal, Nibaldo C Inestrosa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.